US 11464801
Compositions and methods for treating cancer with anti-CD33 immunotherapy
granted A61KA61K2039/505A61K2239/25
Quick answer
US patent 11464801 (Compositions and methods for treating cancer with anti-CD33 immunotherapy) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Oct 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Oct 11 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K2039/505, A61K2239/25, A61K2239/38, A61K39/39558